Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 273-281

  Ben Hur, Herzl ^a   Gurevich, Pavel ^a   Zion, Hagay ^a   Berman, Valentina ^a   Tendler, Yeugeni ^c   Sandler, Bella ^b   Zinder, Oren ^c   Zusman, Igor ^b  

^a KAPLAN HOSPITAL   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Antibodies; Dendritic cells; Immune response; Lymphoid cells; p53; Spleen

Indexed keywords

CARCINOGEN; INTERLEUKIN 2; POLYCLONAL ANTIBODY; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLAST TRANSFORMATION; CANCER INHIBITION; CELL PROLIFERATION; COLON TUMOR; CONTROLLED STUDY; DENDRITIC CELL; GERMINAL CENTER; HISTOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MITOSIS; NEUTROPHIL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE; VACCINATION;

ANIMALS; APOPTOSIS; CANCER VACCINES; CARCINOGENS; COLONIC NEOPLASMS; GERMINAL CENTER; LYMPHOCYTE ACTIVATION; NEOPLASMS, EXPERIMENTAL; RABBITS; RATS; SPLEEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031900058     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Zusman I, Zusman R, Gurevich P, Korol D and Tendler Y: High tumor-preventive effects of polycloncal IgG generated against p53 tumor-associated protein obtained from benign-tumor bearing rats. Oncol Rep 3: 975-979, 1996.
2. Zusman I, Gurevich P, Sandler D, Zusman R, Smirnoff P and Tendler Y: Tumor-suppressor effects of anti-p53 IgG on chemically induced colon cancer in rats. Cancer J 10: 116-120, 1997.
3. Timens W: The human spleen and immune system: Not just another lymphoid organ. Res Immunol 142: 316-320, 1991.
4. Eertwegh van der AJ, Boersma WJ, Chaessen E: Immunological functions and in vivo cell-cell interactions of T cells in the spleen. Crit Rev Immunol 11: 337-348, 1992.
5. Balogh P and Kumanovics A: Tissue-associated phenotypic heterogeneity of peripheral B cells in mice. Immunol 86: 560-567, 1995.
6. Gurevich P, Czemobilsky B, Ben-Hur H, Nyska A, Zuckerman A, Zusman I: Pathology of lymphoid organs in low-birth-weight human fetuses subjected to antigen-induced influences: a morphological and morphometric study. Pediatr Pathol 14: 679-693, 1994.
7. Howard MC, Miyayima A and Coffman R: T cell-derived cytokines and their receptors. In: Paul WE (ed.), Fundamental Immunology. Raven Press, New York, 1993, pp.763-801.
8. Douglas SD and Yoder MC: The mononuclear phagocyte and dendritic cell system. In: Stiehm ER (ed.), Immunologic Disorders in Infants and Children. Saunders, Philadelphia, 1995, pp. 113-132.
9. Garcia-Plata D, Lessana-Leibowitch M, Palangie A, Guillemette J, Sedel D, Mendez L, Mozos E: Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas. Invasion Metastasis 15: 125-134, 1995.
10. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
11. Zhang J and Russell SJ: Vectors for cancer gene therapy. Cancer Metast Rev 15: 385-401, 1996.
12. Laman JD, Claassen E, Noelle RJ: Functions of CD40 and its ligand, gp39 (CD40L). Crit Rev Immunol 16: 59-108, 1996.
13. Grewal IS and Flavell RA: A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 17: 409-414, 1996.
14. Llopis MJP, Harms G, Hardonk MJ and Timens W: Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol 97: 1015-1024, 1996.
15. Braun J and Stiehm ER: The B-lymphocyte system. In: Stiehm ER (ed), Immunologic Disorders in Infants and Children. Saunders, Philadelphia, 1995, pp. 35-74.
16. Nieuwenhuis P and Opstelten D: Functional anatomy of germinal centers. Am J Anat 70: 421-435, 1984.
17. Grekou AN, Toliou T, Stravoravdi P, Patakiouta F, Tsoukalas T, Pinakidis M and Keramidas G: Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas. Anticancer Res 16: 3991-3996, 1996.
18. Loresvazquez B, Pachecocarracedo M, Olivermorales J, Paradagonzalez P and Gambondeze F: Lymphocyte subpopulations of regional lymph nodes in human colon and gastric adenocarcinomas. Cancer'Immunol Immunother 42: 339-342, 1996.
19. Zusman I, Reifen R, Livni O, Smirnoff P, Gurevich P, Sandler B, Nyska A, Gal R, Tendler Y and Madar Z: Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus. Anticancer Res 17: 2105-2114, 1997.
20. Corr M, Lee DJ, Carson DA and Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184: 1555-1560, 1996.
21. Amano T, Nakazawa M, Oshima T, Bosshardt SC and Colley DG. Cross-reactive idiotypes on rabbit anti-SEA antibodies stimulate antiidiotype spleen and lymph node cell responses of mice infected with Schistosoma mansoni. Parasite Immunol 18: 21-28, 1996.
22. Oprea M and Perelson AS. Exploring the mechanisms of primary antibody responses to T cell-dependent antigens. J Theoret Biol 181: 215-236, 1996.
23. Marland G, Bakker AB, Adema GJ and Figdor CG. Dendritic cells in immune response induction. Stem Cells 14: 501-507, 1996.
24. Grouard G, Durand I, Filgueira L, Banchereau J and Liu YJ: Dendritic cells capable of stimulating T cells in germinal centres. Nature 384: 364-367, 1996.